
Eric Olson
Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1673, 1623 |
| Total Applications | 1758 |
| Issued Applications | 971 |
| Pending Applications | 175 |
| Abandoned Applications | 632 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9174981
[patent_doc_number] => 20130316967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'COMPOUNDS AND METHODS FOR ENHANCING ERYTHROPOIESIS'
[patent_app_type] => utility
[patent_app_number] => 13/930849
[patent_app_country] => US
[patent_app_date] => 2013-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6346
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13930849
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/930849 | Compounds and methods for enhancing erythropoiesis | Jun 27, 2013 | Issued |
Array
(
[id] => 9477814
[patent_doc_number] => 20140135277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'SODIUM GLUCOSE CO-TRANSPORTER INHIBITORS AND METHODS OF THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 13/925981
[patent_app_country] => US
[patent_app_date] => 2013-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 23599
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13925981
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/925981 | Sodium glucose co-transporter inhibitors and methods of their use | Jun 24, 2013 | Issued |
Array
(
[id] => 9122076
[patent_doc_number] => 20130288997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'NUCLEOSIDE PHOSPHORAMIDATES'
[patent_app_type] => utility
[patent_app_number] => 13/925078
[patent_app_country] => US
[patent_app_date] => 2013-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 40517
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13925078
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/925078 | Nucleoside phosphoramidates | Jun 23, 2013 | Issued |
Array
(
[id] => 10129403
[patent_doc_number] => 09163230
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-20
[patent_title] => 'Chromatography column and method for isolating nucleic acid'
[patent_app_type] => utility
[patent_app_number] => 13/918979
[patent_app_country] => US
[patent_app_date] => 2013-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5110
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13918979
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/918979 | Chromatography column and method for isolating nucleic acid | Jun 15, 2013 | Issued |
Array
(
[id] => 11581694
[patent_doc_number] => 09636314
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-02
[patent_title] => 'Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome'
[patent_app_type] => utility
[patent_app_number] => 13/917032
[patent_app_country] => US
[patent_app_date] => 2013-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 24
[patent_no_of_words] => 6904
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13917032
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/917032 | Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome | Jun 12, 2013 | Issued |
Array
(
[id] => 9122179
[patent_doc_number] => 20130289101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'THERAPY-ENHANCING GLUCAN'
[patent_app_type] => utility
[patent_app_number] => 13/913953
[patent_app_country] => US
[patent_app_date] => 2013-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12274
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13913953
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/913953 | THERAPY-ENHANCING GLUCAN | Jun 9, 2013 | Abandoned |
Array
(
[id] => 9055201
[patent_doc_number] => 20130252915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'CRYSTALLINE FORMS OF A MACROLIDE, AND USES THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 13/900147
[patent_app_country] => US
[patent_app_date] => 2013-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10104
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13900147
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/900147 | Crystalline forms of a macrolide, and uses therefor | May 21, 2013 | Issued |
Array
(
[id] => 9148949
[patent_doc_number] => 20130303472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'SOLID STATE FORMS OF FIDAXOMYCIN AND PROCESSES FOR PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/896711
[patent_app_country] => US
[patent_app_date] => 2013-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9038
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13896711
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/896711 | Solid state forms of fidaxomycin and processes for preparation thereof | May 16, 2013 | Issued |
Array
(
[id] => 11642147
[patent_doc_number] => 09663503
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-30
[patent_title] => '5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/396338
[patent_app_country] => US
[patent_app_date] => 2013-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17864
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14396338
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/396338 | 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof | May 13, 2013 | Issued |
Array
(
[id] => 11799840
[patent_doc_number] => 09540635
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-10
[patent_title] => 'Buffer for one-step DNA extraction'
[patent_app_type] => utility
[patent_app_number] => 13/889520
[patent_app_country] => US
[patent_app_date] => 2013-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2046
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13889520
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/889520 | Buffer for one-step DNA extraction | May 7, 2013 | Issued |
Array
(
[id] => 9413812
[patent_doc_number] => 08697849
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-15
[patent_title] => 'Pyrazole compounds'
[patent_app_type] => utility
[patent_app_number] => 13/875314
[patent_app_country] => US
[patent_app_date] => 2013-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9124
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13875314
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/875314 | Pyrazole compounds | May 1, 2013 | Issued |
Array
(
[id] => 9043025
[patent_doc_number] => 20130245663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'Devices, Systems and Methods for Treatment of Eating Disorders'
[patent_app_type] => utility
[patent_app_number] => 13/875086
[patent_app_country] => US
[patent_app_date] => 2013-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9601
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13875086
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/875086 | Devices, Systems and Methods for Treatment of Eating Disorders | Apr 30, 2013 | Abandoned |
Array
(
[id] => 9034860
[patent_doc_number] => 20130237498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-12
[patent_title] => 'METHODS OF USE OF BIOMATERIAL AND INJECTABLE IMPLANT CONTAINING BIOMATERIAL'
[patent_app_type] => utility
[patent_app_number] => 13/869559
[patent_app_country] => US
[patent_app_date] => 2013-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3644
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13869559
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/869559 | Methods of use of biomaterial and injectable implant containing biomaterial | Apr 23, 2013 | Issued |
Array
(
[id] => 9212582
[patent_doc_number] => 20140011759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'COMPOSITIONS AND METHODS OF TREATMENT OF DRUG RESISTANT CANCERS'
[patent_app_type] => utility
[patent_app_number] => 13/869012
[patent_app_country] => US
[patent_app_date] => 2013-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 18854
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13869012
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/869012 | Compositions and methods of treatment of drug resistant cancers | Apr 22, 2013 | Issued |
Array
(
[id] => 9895965
[patent_doc_number] => 20150051163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-19
[patent_title] => 'COMBINATION THERAPY FOR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/394463
[patent_app_country] => US
[patent_app_date] => 2013-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 41101
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14394463
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/394463 | Combination therapy for treating cancer | Apr 11, 2013 | Issued |
Array
(
[id] => 9015571
[patent_doc_number] => 20130230535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'THERAPY-ENHANCING GLUCAN'
[patent_app_type] => utility
[patent_app_number] => 13/859096
[patent_app_country] => US
[patent_app_date] => 2013-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 24254
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13859096
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/859096 | Therapy-enhancing glucan | Apr 8, 2013 | Issued |
Array
(
[id] => 10414330
[patent_doc_number] => 20150299340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'PREPARATION OF NEW INTERMEDIATE OF HEPARIN PENTASACCHARIDE AND PREPARATION METHOD THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/389806
[patent_app_country] => US
[patent_app_date] => 2013-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4444
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389806
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/389806 | Preparation of new intermediate of heparin pentasaccharide and preparation method thereof | Apr 1, 2013 | Issued |
Array
(
[id] => 9917749
[patent_doc_number] => 20150072954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-12
[patent_title] => 'PHARMACEUTICAL FORMULATIONS COMPRISING CHONDROITIN SULFATE AND HYALURONIC ACID DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/389301
[patent_app_country] => US
[patent_app_date] => 2013-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4687
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389301
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/389301 | Pharmaceutical formulations comprising chondroitin sulfate and hyaluronic acid derivatives | Mar 26, 2013 | Issued |
Array
(
[id] => 9198774
[patent_doc_number] => 20130338089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'METHODS AND COMPOUNDS FOR MODULATING THE SECRETION OR EXPRESSION OF ADHESION PROTEINS OR ANGIOPOIETINS OF CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/841053
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 42574
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13841053
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/841053 | Methods and compounds for modulating the secretion or expression of adhesion proteins or angiopoietins of cells | Mar 14, 2013 | Issued |
Array
(
[id] => 9055200
[patent_doc_number] => 20130252914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'Macrolide Polymorphs, Compositions Comprising Such Polymorphs, and Methods of Use and Manufacture Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/839299
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12893
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13839299
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/839299 | Macrolide Polymorphs, Compositions Comprising Such Polymorphs, and Methods of Use and Manufacture Thereof | Mar 14, 2013 | Abandoned |